The over-the-counter medicine business is proving to be a lucrative one. And it’s one that is doing well in the current ...

Abstract mash line and point origami on white background with an inscription. Starry sky or space, consisting of stars and the universe. Vector illustration drawing of a medicine stock illustrations ...

Palantir may face tough competition in the software space from this AI titan that made its name selling AI hardware.

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.

Wall Street traders revived prospects for a half-point Federal Reserve rate cut this month, driving stocks to their best week ...

The study builds on a growing body of research suggesting 3D mammography could offer benefits over 2D imaging.

A probable rate cut has provided hope for the economy. Despite that, the impact on financial markets and stocks remains ...

Sean Snaith of the Institute for Economic Forecasting at UCF believes the Fed might want to get more data before cutting ...

Analyst Anne Samuel of J.P. Morgan maintained a Buy rating on Progyny (PGNY – Research Report), reducing the price target to $22.00. Anne ...

The size of the Federal Reserve’s highly anticipated interest-rate cut this week is less relevant for equities than the ...

Finally, after a decade of underperformance in AI-driven medicine, success is approaching ... we’ve reached a tipping point. In the same way the iPhone became an essential part of our lives ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...